Full text is available at the source.
The New England journal of medicine···
Heart health outcomes with Tirzepatide compared to Dulaglutide in Type 2 diabetes
Updated
Related papers
Apr '25
Comparing Increasing Dulaglutide Dose to Switching to Tirzepatide in People with Type 2 Diabetes Not Controlled by Low Dulaglutide
top 2% journal
cited by 10 papers
randomized controlled trial
Oct '18
Safety and effectiveness of LY3298176, a new drug targeting two hormone receptors, in people with type 2 diabetes: a controlled phase 2 trial
top 1% journal
cited by 714 papers
randomized controlled trial
May '24
Expected Effects During the First 12 Weeks After Switching to Tirzepatide 5 mg From Other Diabetes Medicines
top 20% journal
cited by 11 papers
journal article
Feb '16
Heart safety of once-weekly dulaglutide in type 2 diabetes: combined analysis of confirmed heart-related events
top 2% journal
cited by 53 papers
meta-analysis
Mar '26
Safety and effectiveness of switching from dulaglutide to tirzepatide in people with type 2 diabetes across different starting conditions
top 10% journal
randomized controlled trial
Jun '17
Participant details in the REWIND trial studying weekly dulaglutide and heart health in diabetes
cited by 156 papers
research support, non-u.s. gov't
Oct '21
Tirzepatide's effects on fat and metabolism in people with type 2 diabetes
top 5% journal
cited by 101 papers
randomized controlled trial
Aug '22
Effectiveness and safety of tirzepatide alone versus dulaglutide in Japanese adults with type 2 diabetes
top 1% journal
cited by 190 papers
randomized controlled trial
Sep '23
Comparing tirzepatide and dulaglutide on major heart problems in people with type 2 diabetes and artery disease: Study design and starting data
top 5% journal
cited by 204 papers
clinical trial protocol
Jun '19
Dulaglutide and heart-related health in people with type 2 diabetes: a controlled clinical trial
top 1% journal
cited by 2,465 papers
randomized controlled trial
GLP-1 Therapies